These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 29435850)

  • 1. Managing Gout in the Patient with Renal Impairment.
    Pascual E; Sivera F; Andrés M
    Drugs Aging; 2018 Apr; 35(4):263-273. PubMed ID: 29435850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of gout in 2006].
    Cheour E; Ajlani H; Ben Abdelghni K; Sahli H; Farah A; Hamza S; Fendri L; Sellami S
    Tunis Med; 2006 Sep; 84(9):527-31. PubMed ID: 17263196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of gout: a 57-year-old man with a history of podagra, hyperuricemia, and mild renal insufficiency.
    Shmerling RH
    JAMA; 2012 Nov; 308(20):2133-41. PubMed ID: 23188030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Major unanswered questions in the clinical gout field.
    Stamp LK
    Curr Opin Rheumatol; 2017 Mar; 29(2):171-177. PubMed ID: 27926541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac and renal protective effects of urate-lowering therapy.
    Richette P; Latourte A; Bardin T
    Rheumatology (Oxford); 2018 Jan; 57(suppl_1):i47-i50. PubMed ID: 29272510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gout: can we create an evidence-based systematic approach to diagnosis and management?
    Chen LX; Schumacher HR
    Best Pract Res Clin Rheumatol; 2006 Aug; 20(4):673-84. PubMed ID: 16979531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of gout patients with impairment of renal function: a systematic literature review.
    van Echteld IA; van Durme C; Falzon L; Landewé RB; van der Heijde DM; Aletaha D
    J Rheumatol Suppl; 2014 Sep; 92():48-54. PubMed ID: 25180128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Febuxostat on Renal Function in Gout Patients With Moderate-to-Severe Renal Impairment.
    Saag KG; Whelton A; Becker MA; MacDonald P; Hunt B; Gunawardhana L
    Arthritis Rheumatol; 2016 Aug; 68(8):2035-43. PubMed ID: 26894653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gout in solid organ transplantation: a challenging clinical problem.
    Stamp L; Searle M; O'Donnell J; Chapman P
    Drugs; 2005; 65(18):2593-611. PubMed ID: 16392875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urate oxidase (rasburicase) for treatment of severe acute gout: a case report.
    Wipfler-Freibmuth E; Dejaco C; Duftner C; Gaugg M; Kriessmayr-Lungkofler M; Schirmer M
    Clin Exp Rheumatol; 2009; 27(4):658-60. PubMed ID: 19772802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gout.
    Dalbeth N; Merriman TR; Stamp LK
    Lancet; 2016 Oct; 388(10055):2039-2052. PubMed ID: 27112094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allopurinol dosing in renal impairment: walking the tightrope between adequate urate lowering and adverse events.
    Dalbeth N; Stamp L
    Semin Dial; 2007; 20(5):391-5. PubMed ID: 17897242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gout: joints and beyond, epidemiology, clinical features, treatment and co-morbidities.
    Robinson PC; Horsburgh S
    Maturitas; 2014 Aug; 78(4):245-51. PubMed ID: 24880206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lesinurad for the treatment of hyperuricaemia in people with gout.
    Robinson PC; Dalbeth N
    Expert Opin Pharmacother; 2017 Dec; 18(17):1875-1881. PubMed ID: 29103339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gout and its comorbidities: implications for therapy.
    Stamp LK; Chapman PT
    Rheumatology (Oxford); 2013 Jan; 52(1):34-44. PubMed ID: 22949727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allopurinol: insights from studies of dose-response relationships.
    Day RO; Kannangara DR; Stocker SL; Carland JE; Williams KM; Graham GG
    Expert Opin Drug Metab Toxicol; 2017 Apr; 13(4):449-462. PubMed ID: 27927043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gout and secondary amyloid.
    Gumá M; Bayés B; Bonet J; Olivé A
    Clin Rheumatol; 1999; 18(1):54-5. PubMed ID: 10088952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and management of complicated gout.
    Wise CM; Agudelo CA
    Bull Rheum Dis; 1998 Jun; 47(4):2-5. PubMed ID: 9624822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A two-stage approach to the treatment of hyperuricemia in gout: the "dirty dish" hypothesis.
    Perez-Ruiz F; Herrero-Beites AM; Carmona L
    Arthritis Rheum; 2011 Dec; 63(12):4002-6. PubMed ID: 21898351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New treatments for gout.
    Mapa JB; Pillinger MH
    Curr Opin Investig Drugs; 2010 May; 11(5):499-506. PubMed ID: 20419595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.